Industry Research Reports
Home > Reports > Service & Software > One-Stop Service for Gene-Edited Cell Lines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
One-Stop Service for Gene-Edited Cell Lines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-08-23
Pages: 128 Pages
Report ld: 4936169
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
One-Stop Service for Gene-Edited Cell Lines Market Size(US$)
CAGR 2025-2031
13.2%
Market Size,2031
USD 4,566
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,170 million
Market Forecast in 2031(Value)
US$ 4,566 million
CAGR
13.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for One-Stop Service for Gene-Edited Cell Lines was estimated to be worth US$ 1910 million in 2024 and is forecast to a readjusted size of US$ 4566 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Our one-stop gene-edited cell line service is designed for research institutions, biopharmaceutical companies, and clinical translational applications, providing a comprehensive, integrated solution from editing strategy design, gene editing tool construction (such as CRISPR/Cas, TALEN, etc.), cell transfection and screening, monoclonal cell establishment, genotypic and phenotypic verification, to functional analysis and stable cell line delivery. This service can achieve gene knockout, knock-in, point mutation, or multi-gene editing based on customer needs, helping users efficiently obtain high-quality, reproducible, customized cell models, significantly shortening R&D cycles and reducing experimental risks. It meets diverse needs across basic research, drug development, target validation, and early cell therapy development.
North American market for One-Stop Service for Gene-Edited Cell Lines was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for One-Stop Service for Gene-Edited Cell Lines was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for One-Stop Service for Gene-Edited Cell Lines was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of One-Stop Service for Gene-Edited Cell Lines include Amsbio, Charles River Laboratories, Creative Biogene, Cytiva, Eurofins Genomics, Evotec, GenScript, Horizon Discovery, Lonza, ViroCell Biologics, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for One-Stop Service for Gene-Edited Cell Lines, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of One-Stop Service for Gene-Edited Cell Lines by region & country, by Type, and by Application.
The One-Stop Service for Gene-Edited Cell Lines market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding One-Stop Service for Gene-Edited Cell Lines.
MARKET SEGMENTATION
By Company
- Amsbio
- Charles River Laboratories
- Creative Biogene
- Cytiva
- Eurofins Genomics
- Evotec
- GenScript
- Horizon Discovery
- Lonza
- ViroCell Biologics
- Sartorius
- Synbio Technologies
- Takara Bio
- Thermo Fisher Scientific
- BoyaLife
- HEMABIO
- BGI Genomics
- GenScript Biotech
- Shanghai Model Organisms
- Vazyme
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Gene Knockout Service
- Gene Knockin Service
Segment by Application
- Universities and Research Institutions
- Biopharmaceutical Industry
- Others
Segment by Category
- Single Gene Editing Service
- Multiple Gene Joint Editing Service
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of One-Stop Service for Gene-Edited Cell Lines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of One-Stop Service for Gene-Edited Cell Lines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of One-Stop Service for Gene-Edited Cell Lines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 One-Stop Service for Gene-Edited Cell Lines Product Introduction
1.2 Global One-Stop Service for Gene-Edited Cell Lines Market Size Forecast (2020-2031)
1.3 One-Stop Service for Gene-Edited Cell Lines Market Trends & Drivers
1.3.1 One-Stop Service for Gene-Edited Cell Lines Industry Trends
1.3.2 One-Stop Service for Gene-Edited Cell Lines Market Drivers & Opportunity
1.3.3 One-Stop Service for Gene-Edited Cell Lines Market Challenges
1.3.4 One-Stop Service for Gene-Edited Cell Lines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global One-Stop Service for Gene-Edited Cell Lines Players Revenue Ranking (2024)
2.2 Global One-Stop Service for Gene-Edited Cell Lines Revenue by Company (2020-2025)
2.3 Key Companies One-Stop Service for Gene-Edited Cell Lines Manufacturing Base Distribution and Headquarters
2.4 Key Companies One-Stop Service for Gene-Edited Cell Lines Product Offered
2.5 Key Companies Time to Begin Mass Production of One-Stop Service for Gene-Edited Cell Lines
2.6 One-Stop Service for Gene-Edited Cell Lines Market Competitive Analysis
2.6.1 One-Stop Service for Gene-Edited Cell Lines Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by One-Stop Service for Gene-Edited Cell Lines Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in One-Stop Service for Gene-Edited Cell Lines as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gene Knockout Service
3.1.2 Gene Knockin Service
3.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type
3.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Type (2020-2031)
3.2.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Type (%) (2020-2031)
4 Segmentation by Number of Edited Genes
4.1 Introduction by Number of Edited Genes
4.1.1 Single Gene Editing Service
4.1.2 Multiple Gene Joint Editing Service
4.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes
4.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes (2020 VS 2024 VS 2031)
4.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Number of Edited Genes (2020-2031)
4.2.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Number of Edited Genes (%) (2020-2031)
5 Segmentation by Application
5.1 Introduction by Application
5.1.1 Universities and Research Institutions
5.1.2 Biopharmaceutical Industry
5.1.3 Others
5.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application
5.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Application (2020-2031)
5.2.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value, by Application (%) (2020-2031)
6 Segmentation by Region
6.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region
6.1.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region: 2020 VS 2024 VS 2031
6.1.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2020-2025)
6.1.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2026-2031)
6.1.4 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (%), (2020-2031)
6.2 North America
6.2.1 North America One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
6.2.2 North America One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
6.3 Europe
6.3.1 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
6.3.2 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
6.4 Asia Pacific
6.4.1 Asia Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
6.4.2 Asia Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (%), 2024 VS 2031
6.5 South America
6.5.1 South America One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
6.5.2 South America One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
6.6 Middle East & Africa
6.6.1 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
6.6.2 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
7 Segmentation by Key Countries/Regions
7.1 Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Trends, 2020 VS 2024 VS 2031
7.2 Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.3 United States
7.3.1 United States One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.3.2 United States One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.3.3 United States One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.4 Europe
7.4.1 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.4.2 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.4.3 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.5 China
7.5.1 China One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.5.2 China One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.5.3 China One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.6 Japan
7.6.1 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.6.2 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.6.3 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.7 South Korea
7.7.1 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.7.2 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.7.3 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.8 Southeast Asia
7.8.1 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.8.2 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.8.3 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
7.9 India
7.9.1 India One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020-2031
7.9.2 India One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
7.9.3 India One-Stop Service for Gene-Edited Cell Lines Sales Value by Application, 2024 VS 2031
8 Company Profiles
8.1 Amsbio
8.1.1 Amsbio Profile
8.1.2 Amsbio Main Business
8.1.3 Amsbio One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.1.4 Amsbio One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.1.5 Amsbio Recent Developments
8.2 Charles River Laboratories
8.2.1 Charles River Laboratories Profile
8.2.2 Charles River Laboratories Main Business
8.2.3 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.2.4 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.2.5 Charles River Laboratories Recent Developments
8.3 Creative Biogene
8.3.1 Creative Biogene Profile
8.3.2 Creative Biogene Main Business
8.3.3 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.3.4 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.3.5 Creative Biogene Recent Developments
8.4 Cytiva
8.4.1 Cytiva Profile
8.4.2 Cytiva Main Business
8.4.3 Cytiva One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.4.4 Cytiva One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.4.5 Cytiva Recent Developments
8.5 Eurofins Genomics
8.5.1 Eurofins Genomics Profile
8.5.2 Eurofins Genomics Main Business
8.5.3 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.5.4 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.5.5 Eurofins Genomics Recent Developments
8.6 Evotec
8.6.1 Evotec Profile
8.6.2 Evotec Main Business
8.6.3 Evotec One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.6.4 Evotec One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.6.5 Evotec Recent Developments
8.7 GenScript
8.7.1 GenScript Profile
8.7.2 GenScript Main Business
8.7.3 GenScript One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.7.4 GenScript One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.7.5 GenScript Recent Developments
8.8 Horizon Discovery
8.8.1 Horizon Discovery Profile
8.8.2 Horizon Discovery Main Business
8.8.3 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.8.4 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.8.5 Horizon Discovery Recent Developments
8.9 Lonza
8.9.1 Lonza Profile
8.9.2 Lonza Main Business
8.9.3 Lonza One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.9.4 Lonza One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.9.5 Lonza Recent Developments
8.10 ViroCell Biologics
8.10.1 ViroCell Biologics Profile
8.10.2 ViroCell Biologics Main Business
8.10.3 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.10.4 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.10.5 ViroCell Biologics Recent Developments
8.11 Sartorius
8.11.1 Sartorius Profile
8.11.2 Sartorius Main Business
8.11.3 Sartorius One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.11.4 Sartorius One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.11.5 Sartorius Recent Developments
8.12 Synbio Technologies
8.12.1 Synbio Technologies Profile
8.12.2 Synbio Technologies Main Business
8.12.3 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.12.4 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.12.5 Synbio Technologies Recent Developments
8.13 Takara Bio
8.13.1 Takara Bio Profile
8.13.2 Takara Bio Main Business
8.13.3 Takara Bio One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.13.4 Takara Bio One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.13.5 Takara Bio Recent Developments
8.14 Thermo Fisher Scientific
8.14.1 Thermo Fisher Scientific Profile
8.14.2 Thermo Fisher Scientific Main Business
8.14.3 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.14.4 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.14.5 Thermo Fisher Scientific Recent Developments
8.15 BoyaLife
8.15.1 BoyaLife Profile
8.15.2 BoyaLife Main Business
8.15.3 BoyaLife One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.15.4 BoyaLife One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.15.5 BoyaLife Recent Developments
8.16 HEMABIO
8.16.1 HEMABIO Profile
8.16.2 HEMABIO Main Business
8.16.3 HEMABIO One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.16.4 HEMABIO One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.16.5 HEMABIO Recent Developments
8.17 BGI Genomics
8.17.1 BGI Genomics Profile
8.17.2 BGI Genomics Main Business
8.17.3 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.17.4 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.17.5 BGI Genomics Recent Developments
8.18 GenScript Biotech
8.18.1 GenScript Biotech Profile
8.18.2 GenScript Biotech Main Business
8.18.3 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.18.4 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.18.5 GenScript Biotech Recent Developments
8.19 Shanghai Model Organisms
8.19.1 Shanghai Model Organisms Profile
8.19.2 Shanghai Model Organisms Main Business
8.19.3 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.19.4 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.19.5 Shanghai Model Organisms Recent Developments
8.20 Vazyme
8.20.1 Vazyme Profile
8.20.2 Vazyme Main Business
8.20.3 Vazyme One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
8.20.4 Vazyme One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) & (2020-2025)
8.20.5 Vazyme Recent Developments
9 Industry Chain Analysis
9.1 One-Stop Service for Gene-Edited Cell Lines Industrial Chain
9.2 One-Stop Service for Gene-Edited Cell Lines Upstream Analysis
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.2.3 Manufacturing Cost Structure
9.3 Midstream Analysis
9.4 Downstream Analysis (Customers Analysis)
9.5 Sales Model and Sales Channels
9.5.1 One-Stop Service for Gene-Edited Cell Lines Sales Model
9.5.2 Sales Channel
9.5.3 One-Stop Service for Gene-Edited Cell Lines Distributors
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. One-Stop Service for Gene-Edited Cell Lines Market Trends
Table 2. One-Stop Service for Gene-Edited Cell Lines Market Drivers & Opportunity
Table 3. One-Stop Service for Gene-Edited Cell Lines Market Challenges
Table 4. One-Stop Service for Gene-Edited Cell Lines Market Restraints
Table 5. Global One-Stop Service for Gene-Edited Cell Lines Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Company (2020-2025)
Table 7. Key Companies One-Stop Service for Gene-Edited Cell Lines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies One-Stop Service for Gene-Edited Cell Lines Product Type
Table 9. Key Companies Time to Begin Mass Production of One-Stop Service for Gene-Edited Cell Lines
Table 10. Global One-Stop Service for Gene-Edited Cell Lines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in One-Stop Service for Gene-Edited Cell Lines as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Type (2020-2025)
Table 17. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Type (2026-2031)
Table 18. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes (2020-2025) & (US$ Million)
Table 20. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes (2026-2031) & (US$ Million)
Table 21. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Number of Edited Genes (2020-2025)
Table 22. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Number of Edited Genes (2026-2031)
Table 23. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 24. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2020-2025) & (US$ Million)
Table 25. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2026-2031) & (US$ Million)
Table 26. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Application (2020-2025)
Table 27. Global One-Stop Service for Gene-Edited Cell Lines Sales Market Share in Value by Application (2026-2031)
Table 28. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 29. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2020-2025) & (US$ Million)
Table 30. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2026-2031) & (US$ Million)
Table 31. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2020-2025) & (%)
Table 32. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2026-2031) & (%)
Table 33. Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 34. Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2025) & (US$ Million)
Table 35. Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value, (2026-2031) & (US$ Million)
Table 36. Amsbio Basic Information List
Table 37. Amsbio Description and Business Overview
Table 38. Amsbio One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 39. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Amsbio (2020-2025)
Table 40. Amsbio Recent Developments
Table 41. Charles River Laboratories Basic Information List
Table 42. Charles River Laboratories Description and Business Overview
Table 43. Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 44. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Charles River Laboratories (2020-2025)
Table 45. Charles River Laboratories Recent Developments
Table 46. Creative Biogene Basic Information List
Table 47. Creative Biogene Description and Business Overview
Table 48. Creative Biogene One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 49. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Creative Biogene (2020-2025)
Table 50. Creative Biogene Recent Developments
Table 51. Cytiva Basic Information List
Table 52. Cytiva Description and Business Overview
Table 53. Cytiva One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 54. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Cytiva (2020-2025)
Table 55. Cytiva Recent Developments
Table 56. Eurofins Genomics Basic Information List
Table 57. Eurofins Genomics Description and Business Overview
Table 58. Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 59. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Eurofins Genomics (2020-2025)
Table 60. Eurofins Genomics Recent Developments
Table 61. Evotec Basic Information List
Table 62. Evotec Description and Business Overview
Table 63. Evotec One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 64. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Evotec (2020-2025)
Table 65. Evotec Recent Developments
Table 66. GenScript Basic Information List
Table 67. GenScript Description and Business Overview
Table 68. GenScript One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 69. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of GenScript (2020-2025)
Table 70. GenScript Recent Developments
Table 71. Horizon Discovery Basic Information List
Table 72. Horizon Discovery Description and Business Overview
Table 73. Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 74. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Horizon Discovery (2020-2025)
Table 75. Horizon Discovery Recent Developments
Table 76. Lonza Basic Information List
Table 77. Lonza Description and Business Overview
Table 78. Lonza One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 79. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Lonza (2020-2025)
Table 80. Lonza Recent Developments
Table 81. ViroCell Biologics Basic Information List
Table 82. ViroCell Biologics Description and Business Overview
Table 83. ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 84. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of ViroCell Biologics (2020-2025)
Table 85. ViroCell Biologics Recent Developments
Table 86. Sartorius Basic Information List
Table 87. Sartorius Description and Business Overview
Table 88. Sartorius One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 89. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Sartorius (2020-2025)
Table 90. Sartorius Recent Developments
Table 91. Synbio Technologies Basic Information List
Table 92. Synbio Technologies Description and Business Overview
Table 93. Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 94. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Synbio Technologies (2020-2025)
Table 95. Synbio Technologies Recent Developments
Table 96. Takara Bio Basic Information List
Table 97. Takara Bio Description and Business Overview
Table 98. Takara Bio One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 99. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Takara Bio (2020-2025)
Table 100. Takara Bio Recent Developments
Table 101. Thermo Fisher Scientific Basic Information List
Table 102. Thermo Fisher Scientific Description and Business Overview
Table 103. Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 104. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Thermo Fisher Scientific (2020-2025)
Table 105. Thermo Fisher Scientific Recent Developments
Table 106. BoyaLife Basic Information List
Table 107. BoyaLife Description and Business Overview
Table 108. BoyaLife One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 109. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of BoyaLife (2020-2025)
Table 110. BoyaLife Recent Developments
Table 111. HEMABIO Basic Information List
Table 112. HEMABIO Description and Business Overview
Table 113. HEMABIO One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 114. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of HEMABIO (2020-2025)
Table 115. HEMABIO Recent Developments
Table 116. BGI Genomics Basic Information List
Table 117. BGI Genomics Description and Business Overview
Table 118. BGI Genomics One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 119. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of BGI Genomics (2020-2025)
Table 120. BGI Genomics Recent Developments
Table 121. GenScript Biotech Basic Information List
Table 122. GenScript Biotech Description and Business Overview
Table 123. GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 124. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of GenScript Biotech (2020-2025)
Table 125. GenScript Biotech Recent Developments
Table 126. Shanghai Model Organisms Basic Information List
Table 127. Shanghai Model Organisms Description and Business Overview
Table 128. Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 129. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Shanghai Model Organisms (2020-2025)
Table 130. Shanghai Model Organisms Recent Developments
Table 131. Vazyme Basic Information List
Table 132. Vazyme Description and Business Overview
Table 133. Vazyme One-Stop Service for Gene-Edited Cell Lines Products, Services and Solutions
Table 134. Revenue (US$ Million) in One-Stop Service for Gene-Edited Cell Lines Business of Vazyme (2020-2025)
Table 135. Vazyme Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. One-Stop Service for Gene-Edited Cell Lines Downstream Customers
Table 139. One-Stop Service for Gene-Edited Cell Lines Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. One-Stop Service for Gene-Edited Cell Lines Product Picture
Figure 2. Global One-Stop Service for Gene-Edited Cell Lines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global One-Stop Service for Gene-Edited Cell Lines Sales Value (2020-2031) & (US$ Million)
Figure 4. One-Stop Service for Gene-Edited Cell Lines Report Years Considered
Figure 5. Global One-Stop Service for Gene-Edited Cell Lines Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by One-Stop Service for Gene-Edited Cell Lines Revenue in 2024
Figure 7. One-Stop Service for Gene-Edited Cell Lines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Gene Knockout Service Picture
Figure 9. Gene Knockin Service Picture
Figure 10. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Market Share by Type, 2024 & 2031
Figure 12. Single Gene Editing Service Picture
Figure 13. Multiple Gene Joint Editing Service Picture
Figure 14. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Number of Edited Genes (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Market Share by Number of Edited Genes, 2024 & 2031
Figure 16. Product Picture of Universities and Research Institutions
Figure 17. Product Picture of Biopharmaceutical Industry
Figure 18. Product Picture of Others
Figure 19. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 20. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Market Share by Application, 2024 & 2031
Figure 21. North America One-Stop Service for Gene-Edited Cell Lines Sales Value (2020-2031) & (US$ Million)
Figure 22. North America One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
Figure 23. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 24. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
Figure 25. Asia Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 26. Asia Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (%), 2024 VS 2031
Figure 27. South America One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 28. South America One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
Figure 29. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 30. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (%), 2024 VS 2031
Figure 31. Key Countries/Regions One-Stop Service for Gene-Edited Cell Lines Sales Value (%), (2020-2031)
Figure 32. United States One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 33. United States One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 34. United States One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 35. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 36. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 37. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 38. China One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 39. China One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 40. China One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 41. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 42. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 43. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 44. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 45. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 46. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 47. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 48. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 49. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 50. India One-Stop Service for Gene-Edited Cell Lines Sales Value, (2020-2031) & (US$ Million)
Figure 51. India One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (%), 2024 VS 2031
Figure 52. India One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (%), 2024 VS 2031
Figure 53. One-Stop Service for Gene-Edited Cell Lines Industrial Chain
Figure 54. One-Stop Service for Gene-Edited Cell Lines Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global One-Stop Service for Gene-Edited Cell Lines market?
The top companies in the global One-Stop Service for Gene-Edited Cell Lines market are Amsbio、Charles River Laboratories、Creative Biogene.
What is the annual compound growth rate of the global One-Stop Service for Gene-Edited Cell Lines market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of One-Stop Service for Gene-Edited Cell Lines in 2031?
What was the global market size of One-Stop Service for Gene-Edited Cell Lines in 2025?
Related Reports
Global One-Stop Service for Gene-Edited Cell Lines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global One-Stop Service for Gene-Edited Cell Lines market is projected to grow from US$ 2170 million in 2025 to US$ 5108 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 149
USD 4900.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global One-Stop Service for Gene-Edited Cell Lines market size was US$ 2170 million in 2025 and is forecast to reach a readjusted size of US$ 5108 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 110
USD 4250.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Market Research Report 2026
The global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ 2170 million in 2025 and is anticipated to reach US$ 5108 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 134
USD 2900.00
(Single User License)
One-Stop Service for Gene-Edited Cell Lines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for One-Stop Service for Gene-Edited Cell Lines was estimated to be worth US$ 2170 million in 2025 and is projected to reach US$ 5108 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 126
USD 3950.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global One-Stop Service for Gene-Edited Cell Lines market size was US$ 1910 million in 2024 and is forecast to a readjusted size of US$ 4566 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published Date: 2025-08-23
Pages: 107
USD 4250.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Market Research Report 2025
The global market for One-Stop Service for Gene-Edited Cell Lines was valued at US$ 1910 million in the year 2024 and is projected to reach a revised size of US$ 4566 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published Date: 2025-08-23
Pages: 99
USD 2900.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global One-Stop Service for Gene-Edited Cell Lines market is projected to grow from US$ 1910 million in 2024 to US$ 4566 million by 2031, at a CAGR of 13.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-23
Pages: 153
USD 4900.00
(Single User License)
Global One-Stop Service for Gene-Edited Cell Lines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global One-Stop Service for Gene-Edited Cell Lines market is projected to grow from US$ 2170 million in 2025 to US$ 5108 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 149
USD 4900.00 (Single User License)Global One-Stop Service for Gene-Edited Cell Lines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global One-Stop Service for Gene-Edited Cell Lines market size was US$ 2170 million in 2025 and is forecast to reach a readjusted size of US$ 5108 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 110
USD 4250.00 (Single User License)Global One-Stop Service for Gene-Edited Cell Lines Market Research Report 2026
The global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ 2170 million in 2025 and is anticipated to reach US$ 5108 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 134
USD 2900.00 (Single User License)One-Stop Service for Gene-Edited Cell Lines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for One-Stop Service for Gene-Edited Cell Lines was estimated to be worth US$ 2170 million in 2025 and is projected to reach US$ 5108 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 126
USD 3950.00 (Single User License)Global One-Stop Service for Gene-Edited Cell Lines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global One-Stop Service for Gene-Edited Cell Lines market size was US$ 1910 million in 2024 and is forecast to a readjusted size of US$ 4566 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published: 2025-08-23
Pages: 107
USD 4250.00 (Single User License)Global One-Stop Service for Gene-Edited Cell Lines Market Research Report 2025
The global market for One-Stop Service for Gene-Edited Cell Lines was valued at US$ 1910 million in the year 2024 and is projected to reach a revised size of US$ 4566 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published: 2025-08-23
Pages: 99
USD 2900.00 (Single User License)Global One-Stop Service for Gene-Edited Cell Lines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global One-Stop Service for Gene-Edited Cell Lines market is projected to grow from US$ 1910 million in 2024 to US$ 4566 million by 2031, at a CAGR of 13.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-23
Pages: 153
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now